These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23249852)

  • 21. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECDC public consultation on the use of neuraminidase inhibitors.
    Eurosurveillance editorial team
    Euro Surveill; 2016; 21(7):pii=30140. PubMed ID: 27358927
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing seasonal influenza: oseltamivir treatment policy in indonesia?
    Kosasih H; Bratasena A; Pangesti K; Laras K; Samaan G
    Acta Med Indones; 2014 Jan; 46(1):58-65. PubMed ID: 24760811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial.
    Li ZT; Li L; Chen TT; Li CY; Wang DQ; Yang ZF; Zhong NS
    Trials; 2015 Mar; 16():126. PubMed ID: 25873046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells.
    Lu Y; Hardes K; Dahms SO; Böttcher-Friebertshäuser E; Steinmetzer T; Than ME; Klenk HD; Garten W
    Antiviral Res; 2015 Aug; 120():89-100. PubMed ID: 26022200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamiflu: what dermatologists need to know.
    Bergstrom KG
    J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
    Cinti S; Chenoweth C; Monto AS
    Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of antiviral effectiveness in influenza virus A subtype H5N1.
    Chan PK; Lee N; Zaman M; Adisasmito W; Coker R; Hanshaoworakul W; Gasimov V; Oner AF; Dogan N; Tsang O; Phommasack B; Touch S; Bamgboye E; Swenson A; Toovey S; Dreyer NA
    J Infect Dis; 2012 Nov; 206(9):1359-66. PubMed ID: 22927451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.
    Toriumi Y; Kamei T; Murata K; Takahashi I; Suzuki N; Mazda O
    Forsch Komplementmed; 2012; 19(4):179-86. PubMed ID: 22964983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
    Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
    Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible case scenarios and logistic issues in H5N1 pandemic.
    Tsang KW; Shim YS; Wong TK; Liam CK; Eng P; Lam WK; Seto WH
    Respirology; 2006 Sep; 11(5):520-2. PubMed ID: 16916322
    [No Abstract]   [Full Text] [Related]  

  • 39. Uncertainty still surrounds oseltamivir after 13 year old dies.
    Parry J
    BMJ; 2006 Jan; 332(7532):5. PubMed ID: 16399712
    [No Abstract]   [Full Text] [Related]  

  • 40. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
    Haidari M; Ali M; Ward Casscells S; Madjid M
    Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.